May 1, 2018 / 1:10 PM / 7 months ago

BRIEF-Aptevo Therapeutics Announces IND Submission For APVO436

May 1 (Reuters) - Aptevo Therapeutics Inc:

* APTEVO THERAPEUTICS ANNOUNCES IND SUBMISSION FOR APVO436

* APTEVO THERAPEUTICS INC - ON TRACK TO COMMENCE PHASE 1 CLINICAL TRIAL OF APVO436 IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME IN Q4 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below